Journal of Antimicrobial Chemotherapy

Douthwaite, S. and Champney, W.S. (2001) Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. The Journal of Antimicrobial Chemotherapy, 48 (Suppl 2), 1. [Pg.258]

Milazzo, L, Piazza, M., Sangaletti, O., Gatti, N., Cappelletti, A., Adorni, F., Antinori, S., Galli, M., Moroni, M. and Riva, A. (2005) [13C]Methionine breath test a novel method to detect antiretroviral drug-related mitochondrial toxicity. Journal of Antimicrobial Chemotherapy, 55 (1), 84—89. [Pg.380]

Ball P. (2000). Quinolone-induced QT interval prolongation A not-so unexpected class effect. Journal of Antimicrobial Chemotherapy 45 557-559. [Pg.253]

Brighty K.E. and T.D. Gootz (1997). The chemistry and biological profile of trovafloxacin. Journal of Antimicrobial Chemotherapy 39(Suppl. B) l-14. [Pg.255]

Palkiner P.R. (1998). The consequences of antibiotic use in horticulture. Journal of Antimicrobial Chemotherapy 41 429-431. [Pg.261]

Halling-Sdrensen B., H.C. Holten Liitzhpft, H.R. Andersen, and F. Ingerslev (2000). Environmental risk assessment of antibiotics Comparison of mecillinam, trimethoprim and ciprofloxacin. Journal of Antimicrobial Chemotherapy 46(Suppl. Sl) 53-58. [Pg.264]

Hawkey P. (2003). Mechanisms of quinolone action and microhial response. Journal of Antimicrobial Chemotherapy 51(Suppl Sl) 29-35. [Pg.265]

Hiramatsu K., H. Hanaki, T. Ino, K. Yahuta, T. Oguri, and F.C. Tenover (1997). MethiciUin-resistant Staphylococcus aureus chnical strains with reduced vancomycin susceptihihty. Journal of Antimicrobial Chemotherapy 40 135-136. [Pg.266]

Kiimmerer K. (2004a). Resistance in the environment. Journal of Antimicrobial Chemotherapy 54 311-320. [Pg.271]

McCann S.J., O. White, and B. Keevil (2002). Assay of teicoplanin in serum Comparison of high-performance liquid chromatography and fluorescence polarization immunoassay. Journal of Antimicrobial Chemotherapy 50 107-110. [Pg.275]

Munoz-Bellido J.L., S. Munoz-Criado, and J.A. Garcia-Rodriguez (1996). In vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2). Journal of Antimicrobial Chemotherapy 37 1005-1009. [Pg.277]

Stass H. and D. Kubitza (1999). Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. Journal of Antimicrobial Chemotherapy 43(Suppl. B) 83-90. [Pg.285]

Wise R. (2002). Antimicrohial reistance Priorities for action. Journal of Antimicrobial Chemotherapy 49 585-560. [Pg.291]

Kiimmerer K. Significance of Antibiotics in the Environment. Journal of Antimicrobial. Chemotherapy 2003 52 5-7. [Pg.146]

Timmis, K. N., Gonzalez-Carrero, M. I., Sekizaki, T. Rojo, F. (1986). Biological activities specified by antibiotic resistance plasmids. Journal of Antimicrobial Chemotherapy, 18 (Suppl. C), 1-12. [Pg.389]

Reuter, S., Jensen, B., Buttenschoen, K., Wolfgang, K. and Kern, P. (2000) Benzimidazoles in the treatment of alveolar echinococcosis a comparative study and review of the literature, journal of Antimicrobial Chemotherapy 46, 451-456. [Pg.253]

Walker, M., Rossignol, J.F.G., Torgerson, P. and Hemphill, A. (2004) In vitro effects of nitazoxanide on Echinococcus granulosus protoscolices and metacestodes. Journal of Antimicrobial Chemotherapy (advanced publication) 54, 609-616. [Pg.254]

Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown PD, Winship PD, Reid HJ. Silver nanoparticles and polymeric medical devices a new approach to prevention of infection Journal of Antimicrobial Chemotherapy 2004,54,1019-1024. [Pg.264]

Goodacre R, Rooney PJ, Kell DB (1998) Journal of Antimicrobial Chemotherapy 41 27... [Pg.109]

Gemmell CG, Edwards Dl, Fraise AP et al.(2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. journal of Antimicrobial Chemotherapy 57 589-608. [Pg.114]

Sato, K., Sato, N., Shimizu, H., Tsutiya, T., Takahashi, H., Kakizaki, S., Takayama, H., Takagi, H., and Mori, M. (1999). Faropenem enhances superoxide anion production by human neutrophils in vitro Journal of Antimicrobial Chemotherapy AA-. 337-341. [Pg.291]

Livermore D M. Quinupristin/dalfopristin and linezolid where, when, which and whether to use Journal of Antimicrobial Chemotherapy 2000 46 347-350. [Pg.230]

Simmons N A1993 Recommendations for endocarditis prophylaxis. Journal of Antimicrobial Chemotherapy 31 437. Littler W A, McGowan D A, Shanson D C 1997 Changes in recommendations about amoxycillin prophylaxis for prevention of endocarditis. Lancet 350 1100. [Pg.243]

Deray G. Amphotericin B nephrotoxicity. Journal of Antimicrobial Chemotherapy 2002 49 37-41. [Pg.350]

Lid man C, Bronner U, Gustafsson LL, Rombo L. Plasma pentamidine concentrations vary between individuals with Pneumocystis carinii pneumonia and the drug is actively secreted bythe kidney. The Journal of antimicrobial chemotherapy. 1994 Apr 33(4) 803-10. [Pg.376]

Poola NR, Kalis M, Plakogiannis FM,Taft DR. Characterization of pentamidine excretion in the isolated perfused rat kidney. The Journal of antimicrobial chemotherapy. 2003 Sep 52(3) 397-404. [Pg.377]

Johnson PR, Liu Yin JA,Tooth JA. A randomized trial of high-dose ciprofloxacin versus aziocillin and netilmicin in the empirical therapy of febrile neutropenic patients. The Journal of antimicrobial chemotherapy. 1992 Aug 30(2) 203-14. [Pg.379]

Ball P. Ciprofloxacin an overview of adverse experiences.The Journal of antimicrobial chemotherapy. 1986 Nov l 8 SuppI D 187-93. [Pg.379]

Elston RA, Taylor J. Possible interaction of ciprofloxacin with cyclosporin A. The Journal of antimicrobial chemotherapy. 1988 May 21(5) 679-80. [Pg.381]

Norrby SR, Pernet AG. Assessment of adverse events during drug development experience with temafloxacin. The Journal of antimicrobial chemotherapy. 1991 Dec 28 SuppI C 111 -9. [Pg.381]

Praise AP (2002) Biocide abuse and antimicrobial resistance - A cause for concern Journal of Antimicrobial Chemotherapy 49 11-12. [Pg.280]

Journal of Antimicrobial Chemotherapy 48 463-478. Del Rosso JQ (2003) Cephalosporins in dermatology. [Pg.502]

Journal of Antimicrobial Chemotherapy—This British publication addresses all aspects of infectious diseases pharmacotherapy and therapeutics. Both American and European authors contribute to this journal. A review article at the beginning of each issue addresses a pertinent clinical issue. Supplements are published regularly that... [Pg.472]

Zhang, L Li, X.Z. and Poole, K. (2001) Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia. The Journal of Antimicrobial Chemotherapy, 48 (4), 549-552. [Pg.495]

Vermes A, Guohelaar HJ, Dankert J. Flucytosine a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. Journal of Antimicrobial Chemotherapy, 2000, 46 171-179. [Pg.436]

AeschUmarm, J.R., Kaatz, G.W., and Rybak, M.J. (1999) The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model. The Journal of Antimicrobial Chemotherapy, 44 (3), 343-349. [Pg.153]

Avrain, L, Carvey M., Mesaros. N.. Clupczynski, Y, Mingeot-Leclercq. M.P., Piddock, L,J, Tulkens, P.M., Vanhoof, R., and Van Bambeke, F, (2007) Selection of qiunolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. The Journal of Antimicrobial Chemotherapy 60 (5), 965-972. [Pg.154]

Schumacher, A., Steinke, P., Bohnert. J.A., Akova, M., Jonas, D., and Kern, W.V. (2006) Effect of l-(l-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. The Journal of Antimicrobial Chemotherapy, 57 (2), 344—348. [Pg.155]

Barker, K.S.. Pearson, M.M., and Rogers, P.D. (2003) Identification of genes differentiaUy expressed in association with reduced azole susceptibility in Saccharomyces cerevisiae. The Journal of Antimicrobial Chemotherapy. 51, 1131-1140. [Pg.181]

Brun, S., Dalle, F., Saulnier, P., Renier, G., Bonnin, A., Chabasse, D., and Bouchara, J.P. (2005) Biological consequences of petite mutations in Candida glabrata. The Journal of Antimicrobial Chemotherapy, 56, 307—314. [Pg.190]

Metzler, L., Takano, Y, Chihana, H., and Niimi, M. (2007) The Candida glabrata putative sterol transporter gene CgAUSl protects cells against azoles in the presence of serum. The Journal of Antimicrobial Chemotherapy, 60, 1264-1272. [Pg.190]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...